First-line therapy in drug reaction with eosinophilia and systemic symptoms (DReSS): Thinking beyond corticosteroids.

Verstegen, Ruud H J; Phillips, Elizabeth J; Juurlink, David N

Verstegen, Ruud H J; Phillips, Elizabeth J; Juurlink, David N.

Afiliación

Verstegen RHJ; Department of Paediatrics, University of Toronto, Toronto, ON, Canada.
Phillips EJ; Division of Clinical Pharmacology and Toxicology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada.
Juurlink DN; Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada.

Front Med (Lausanne) ; 10: 1138464, 2023.

Article en En | MEDLINE | ID: mdl-36844223

Palabras clave

DReSS (drug reaction with eosinophilia and systemic symptoms); adverse (side) effects; cyclosporine; severe cutaneous adverse drug reaction; targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Front Med (Lausanne) Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google